Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $82
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst David Macdonald maintains a 'Buy' rating on Encompass Health (NYSE:EHC) and raises the price target from $75 to $82.
August 04, 2023 | 1:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Encompass Health's price target has been raised from $75 to $82 by Truist Securities, which maintains a 'Buy' rating on the stock.
The raised price target indicates that the analyst believes the stock has potential for further growth. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100